AO Research Institute Davos, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland.
AO Research Institute Davos, Switzerland.
Osteoarthritis Cartilage. 2019 Jul;27(7):1094-1105. doi: 10.1016/j.joca.2019.04.002. Epub 2019 Apr 16.
This study aimed to characterize the mesenchymal stem cell (MSC) subpopulation migrating towards a degenerated intervertebral disc (IVD) and to assess its regenerative potential.
Based on initial screening for migration towards C-C motif chemokine ligand 5 (CCL5), the migration potential of CD146+ and CD146- mesenchymal stem cells (MSCs) was evaluated in vitro and in a degenerated organ culture model (degeneration by high-frequency loading in a bioreactor). Discogenic differentiation potential of CD146+ and CD146- MSCs was investigated by in vitro pellet culture assay with supplementation of growth and differentiation factor-6 (GDF6). Furthermore, trypsin degenerated IVDs were treated by either homing or injection of CD146+ or CD146- MSCs and glycosaminoglycan synthesis was evaluated by Sulphur 35 incorporation after 35 days of culture.
Surface expression of CD146 led to a higher number of migrated MSCs both in vitro and in organ culture. CD146+ and CD146- pellets responded with a similar up-regulation of anabolic markers. A higher production of sulfated glycosaminoglycans (sGAG)/DNA was observed for CD146+ pellets, while in organ cultures, sGAG synthesis rate was higher for IVDs treated with CD146- MSCs by either homing or injection.
The CD146+ MSC subpopulation held greater migration potential towards degenerative IVDs, while the CD146- cells induced a stronger regenerative response in the resident IVD cells. These findings were independent of the application route (injection vs migration). From a translational point of view, our data suggests that CD146+ MSCs may be suitable for re-population, while CD146- MSCs may represent the primary choice for stimulation of endogenous IVD cells.
本研究旨在描述向退变椎间盘中迁移的间充质干细胞(MSC)亚群,并评估其再生潜能。
基于对趋化因子 C-C 基序配体 5(CCL5)趋化性的初步筛选,评估了 CD146+和 CD146-间充质干细胞(MSC)在体外和退变器官培养模型(在生物反应器中高频加载致退变)中的迁移潜能。通过补充生长分化因子-6(GDF6)的体外微球体培养试验,研究了 CD146+和 CD146- MSC 的椎间盘源性分化潜能。此外,用胰蛋白酶处理退变椎间盘中,并分别注射或归巢 CD146+或 CD146- MSC,35 天后通过 35S 掺入法评估糖胺聚糖合成。
CD146 的表面表达导致体外和器官培养中迁移的 MSC 数量更多。CD146+和 CD146-微球体对合成代谢标志物的上调反应相似。与 CD146-微球体相比,CD146+微球体的硫酸化糖胺聚糖(sGAG)/DNA 产量更高,而在器官培养中,通过归巢或注射用 CD146- MSC 处理的椎间盘中,sGAG 合成率更高。
CD146+MSC 亚群向退变椎间盘中具有更大的迁移潜能,而 CD146-细胞在原位椎间盘细胞中诱导更强的再生反应。这些发现与应用途径(注射与归巢)无关。从转化的角度来看,我们的数据表明 CD146+MSC 可能适合再定植,而 CD146- MSC 可能是刺激内源性椎间盘细胞的首选。